Your session is about to expire
← Back to Search
Study Summary
This trial will test the safety and effectiveness of GSK4172239D in SCD patients.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't taken any drugs or supplements that could affect the study in the last 7 to 14 days, except for low-dose acetaminophen.I have not used hydroxyurea or decitabine in the last 9 weeks.I have a history of serious heart problems.I do not have any major health issues that could affect how my body handles medication.I only use drugs for medical reasons, like pain or anxiety, as prescribed by my doctor.I have not had a blood transfusion in the last 3 months.I have SCD and am not on medication that increases fetal hemoglobin.I have sickle cell disease and previous treatments didn't work for me.My weight is over 50 kilograms.I understand the study and can agree to participate.I tested positive for drugs or alcohol, but I use opioids for pain or benzodiazepines for anxiety as prescribed.I am a male and will not donate sperm. I will either abstain from sex or use reliable birth control methods.I am a woman who cannot become pregnant.
- Group 1: Cohort 3
- Group 2: Cohort 2
- Group 3: Cohort 5
- Group 4: Cohort 1
- Group 5: Food effect cohort
- Group 6: Cohort 4
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Cohort 5 received governmental authorization from the FDA?
"Cohort 5 is rated a 1 on our scale due to the fact that this Phase 1 trial has only limited evidence backing its safety and efficacy."
Are there still opportunities for people to take part in this trial?
"Clinicaltrials.gov verifies that recruitment for this medical trial is no longer underway, as the posting was initially published on February 3rd 2023 and last updated January 23rd 2023. Nevertheless, there are a plethora of other trials currently admitting patients to participate."
What are the qualifications necessary to partake in this medical experiment?
"This medical trial is recruiting 40 individuals with a blood disorder, aged 18 to 50. To be eligible, they must have a body weight of more than 50 kilograms and meet other requirements including the inability to give birth (for female participants) and refraining from donating sperm or using contraception while engaging in intercourse with women of childbearing potential (for male participants). Furthermore, those who are taking medication which increases gamma-globin and failed or not tolerated approved therapies for SCD may also qualify."
Share this study with friends
Copy Link
Messenger